Life Sciences and Medical Technologies

The Life Sciences industry in the midst of an unprecedented period of discovery and innovation in basic science, human disease, therapeutics, and patient care.  Early successes in cell and gene therapy, precision medicine, and bioprocessing have catalyzed staggering amounts of capital investment in both clinical applications and the manufacturing technologies that enable them.
With over 50 transactions in Life Sciences and Healthcare, EC M&A is a leading M&A advisor in this market.
EC M&A is a member of the Alliance for Regenerative Medicine.